US Broker Ratings

Warby Parker Inc. (WRBY) Stock Analysis: 12.88% Potential Upside Beckons Investors

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, continues to attract investor interest with its innovative business model and impressive growth trajectory. As a company operating..

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 11% Potential Upside in the Medical Devices Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices industry, is capturing investor attention with its intriguing mix of growth potential and compelling market position. Headquartered in London,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Potential 32% Upside Captures Investor Attention

As investors continuously seek promising opportunities in the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) stands out with a compelling potential upside of 32.16%, according to recent analyst ratings...

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Reveals 34% Upside Potential Amid Robust CNS Pipeline

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company specializing in central nervous system (CNS) disorders, is gaining attention from investors looking for promising growth potential in the healthcare sector. With..

Galapagos NV (GLPG) Stock Analysis: Navigating a Volatile Biotech Landscape with a -16.40% Investor Outlook

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, has carved out a niche in the healthcare sector with its focus on innovative treatments in oncology and immunology. Despite its promising..

GeneDx Holdings Corp. (WGS): Investor Outlook Highlights 86.32% Potential Upside Amid Robust Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a key player in the diagnostics and research sector, has captured investor attention with its promising growth potential and a significant upside opportunity. As a..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 31% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a significant player in the healthcare sector focused on diagnostic testing solutions, presents an intriguing opportunity for investors eyeing the medical devices industry. With its current..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: An 82.74% Potential Upside Drives Market Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is gaining traction within the biotechnology sector, primarily due to its promising portfolio of novel therapeutics targeting rare endocrine diseases. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling Robust Growth Potential with a 57% Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of biopharmaceutical innovation, focusing on the discovery and development of therapies for neurodegenerative and lysosomal storage diseases. As the company continues..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Founded in 2013 and headquartered in Orange,..

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing an 88.83% Potential Upside

For investors eyeing the healthcare sector, Surgery Partners, Inc. (NASDAQ: SGRY) presents an intriguing opportunity, particularly given the notable potential upside of 88.83% suggested by current analyst target prices. As..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Unlocking a 24% Upside Potential

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is capturing the attention of savvy investors with its impressive growth trajectory and robust product pipeline. As a biopharmaceutical company centered in the healthcare..

Sotera Health Company (SHC) Stock Analysis: Healthcare Sector’s Promising 17% Upside

Sotera Health Company (NASDAQ: SHC), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with a reported potential upside of 17.39%...

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals a Promising 168% Potential Upside

As the healthcare sector continues to capture investor attention, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out with its focus on rare and ultra-rare genetic diseases. Despite a recent dip in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generics Market

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic pharmaceuticals. With a market capitalization..

Alvotech (ALVO) Investor Outlook: Exploring a 331% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) stands out in the healthcare sector as a burgeoning force in the biosimilars market, poised for significant growth. With a market capitalization of $1.6 billion, Alvotech operates..

Merus N.V. (MRUS) Stock Analysis: Evaluating a 7.78% Potential Upside in the Biotech Sector

Merus N.V. (MRUS), a biotechnology company at the forefront of immuno-oncology, presents an intriguing opportunity for investors keen on the healthcare sector. Headquartered in Utrecht, Netherlands, Merus is dedicated to..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 40% Upside Potential in Biotech Innovation

NewAmsterdam Pharma Company N.V. (NAMS) is making waves in the biotechnology sector with its innovative approach to treating metabolic diseases. As a late-stage biopharmaceutical company headquartered in Naarden, Netherlands, NewAmsterdam..

Concentra Group Holdings (CON): Analyzing a 23% Upside Potential in Healthcare

Concentra Group Holdings Parent, Inc. (CON) is positioning itself as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Based in Addison, Texas, this company..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a 67.85% Potential Upside in the Biotechnology Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology industry, has captured the attention of investors with its promising pipeline of innovative therapies and a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds